Greg Pyszczymuka
Chief Commercial Officer, AYTU BIOPHARMA, INC.
Companies
- Evoke Pharma IncBoard member Feb 24, 2025 to now1
- AYTU BIOPHARMA, INCChief Commercial Officer Nov 15, 2022 to now2
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- AYTU BIOPHARMA, INC AYTU56,102 shares3$115.0K at $2.05Jul 28, 2026
- Evoke Pharma Inc0 shares4Feb 24, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 28, 2026Granted 20,000 shares of AYTU BIOPHARMA, INC3
- Oct 3, 2025Granted 12,500 shares of AYTU BIOPHARMA, INC5
- Mar 31, 2025Exercised options 209 shares of AYTU BIOPHARMA, INC6
- Dec 31, 2024Exercised options 208 shares of AYTU BIOPHARMA, INC7
- Sep 30, 2024Exercised options 209 shares of AYTU BIOPHARMA, INC8
- Jun 30, 2024Exercised options 208 shares of AYTU BIOPHARMA, INC9
- Mar 31, 2024Exercised options 208 shares of AYTU BIOPHARMA, INC10
- Dec 31, 2023Exercised options 209 shares of AYTU BIOPHARMA, INC11
- Sep 30, 2023Exercised options 208 shares of AYTU BIOPHARMA, INC12
- Jun 30, 2023Exercised options 208 shares of AYTU BIOPHARMA, INC13
- Jun 16, 2023Bought 12,000 shares at $1.87 of AYTU BIOPHARMA, INC14
- Apr 25, 2023Exercised options 833 shares of AYTU BIOPHARMA, INC15
- Dec 19, 2022Bought 100,000 shares at $0.24 of AYTU BIOPHARMA, INC16
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGAREvoke Pharma Inc, Board member
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Oct 7, 2025
- 6SEC EDGARForm 4 filed Mar 31, 2025
- 7SEC EDGARForm 4 filed Jan 2, 2025
- 8SEC EDGARForm 4 filed Oct 2, 2024
- 9SEC EDGARForm 4 filed Jul 2, 2024
- 10SEC EDGARForm 4 filed Apr 2, 2024
- 11SEC EDGARForm 4 filed Jan 2, 2024
- 12SEC EDGARForm 4 filed Oct 3, 2023
- 13SEC EDGARForm 4 filed Jul 6, 2023
- 14SEC EDGARForm 4 filed Jun 20, 2023
- 15SEC EDGARForm 4 filed Jun 20, 2023
- 16SEC EDGARForm 4 filed Dec 21, 2022